|
| |
| | | 41304 | | 09.03.1984 | | Takeda Pharma AG | | | | | | | | | | | | | 06.01.10. | | | | 06.01.10. | | IP |
| | Seq.-No. | Product | Description | Galenic form | ATC-classification | |
|---|
| 01 | Faktor VII NF Baxter | | Lyophilisate () | B02BD05 | | | 05 | Faktor VII NF Takeda | Pulver und Lösungsmittel zur Herstellung einer Injektionslösung | Lyophilisate and solvent (Proteinum Human 50-200 mg) | B02BD05 | |
|
|
|
